+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024 - Product Thumbnail Image

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
mRNA Therapeutics and mRNA Vaccines Market by Route of Administration, Therapeutic Area, and Geography: Global Trends and Industry Analysis, 2022-2035 - Product Thumbnail Image

mRNA Therapeutics and mRNA Vaccines Market by Route of Administration, Therapeutic Area, and Geography: Global Trends and Industry Analysis, 2022-2035

  • Report
  • October 2022
  • 330 Pages
  • Global
From
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems - Product Thumbnail Image

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

  • Report
  • June 2023
  • 174 Pages
  • Global
From
Hepatitis C Treatment: Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 208 Pages
  • Global
From
Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • April 2022
  • 552 Pages
  • Global
From
mRNA Synthesis and Manufacturing Services Market by Type of Product and Drug Products, Application Area, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

mRNA Synthesis and Manufacturing Services Market by Type of Product and Drug Products, Application Area, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • December 2022
  • 165 Pages
  • Global
From
Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions - Product Thumbnail Image

Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions

  • Report
  • February 2024
  • 867 Pages
  • Global
From
COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025 - Product Thumbnail Image

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

  • Report
  • July 2020
  • 100 Pages
  • Global
From
Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • June 2022
  • 124 Pages
  • Global
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules) - Product Thumbnail Image

US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules)

  • Report
  • January 2024
  • 292 Pages
  • United States
From
Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • October 2023
  • 552 Pages
  • Global
From
Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • August 2023
  • 664 Pages
  • Global
From
Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
HIV Drugs: Global Strategic Business Report - Product Thumbnail Image

HIV Drugs: Global Strategic Business Report

  • Report
  • April 2024
  • 164 Pages
  • Global
From
Biosimilars and Follow-On Biologics Market Report 2023-2033 - Product Thumbnail Image

Biosimilars and Follow-On Biologics Market Report 2023-2033

  • Report
  • December 2022
  • 337 Pages
  • Global
From
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412 - Product Thumbnail Image

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412

  • Report
  • January 2024
  • 89 Pages
  • United States
From
Liver Diseases Treatment: Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report

  • Report
  • April 2024
  • 179 Pages
  • Global
From
Loading Indicator